Charlie Rodi
Founder and CSO
Dr. Rodi has over 30 years of leadership in both Big Pharma and Biotech start-ups. He has brought products to the marketplace for genetic analysis and molecular diagnostics and has led teams involved in drug screeing, cancer diagnostics, and antineoplastic therapeutics. Dr. Rodi received a Ph.D. from the University of Minnesota and performed post-doctoral studies at the NIH.